ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung - Cancer

March 16, 2015
With the increase in solitary pulmonary nodule identification anticipated with increased CT screening, the authors devised a novel method of bronchoscopically biopsying nodules not adjacent to airways.  Using endoscopic instruments, a transparenchymal tunnel was created between a bronchial entry point to the nodule, and biopsies were obtained.  The p
March 13, 2015
Worldwide, lung cancer is a leading cause of death. Minimally invasive resection of small pulmonary nodules is an opportunity and a challenge at the same time. The smaller the nodule, the better the long-term outlook for the patient, but the more difficult the resection. An efficient solution can be found in intra-operative 3D imaging and guided navigation.
March 12, 2015
Samples from tissue microarrays of 552 NSCLC patients were analyzed to measure the levels of 3 different tumor-infiltrating lymphocytes (TILs): CD3, CD8, and CD20. An elevated level of CD3 or CD8 was associated with longer survival.
March 9, 2015
This video demonstrates how to create a subxiphoid port for use in wedge resection, lobectomy, or segmentectomy for lung cancer.
February 21, 2015
Indications for postoperative radiation therapy (PORT) for resected lung cancer are unclear.  This study evaluated outcomes from the National Cancer Data Base 2004-2006, including 2115 patients resected with pathologic N2 NSCLC, of whom  918 (43%) received PORT.  PORT was associated with better median survival (42 vs 38 mos, p=0.048) and was associat
February 21, 2015
SEER outcomes from 1973-2010 were evaluated, including a total of over 947,000 pts, of whom only 441 had atypical carcinoid tumors of the lung.  69% were women and 87% were white.  20% had stage IV disease at diagnosis.  78% of the patients underwent resection.  3-year survival was 85% for N0, 69% for N1-2, and 26% for stage IV.
February 16, 2015
This video shows a very rare vascular injury occurring during VATS left upper lobectomy, and its repair. The case suggests some of the limitations of VATS procedures.
February 16, 2015
Usually patients with prior cancer are excluded in lung cancer trials, but the impact on survival in lung cancer is not known. In a cohort of 102929 patients older than 65 with stage IV lung cancer, a propensity score analysis were performed and found that patients with prior cancer had better survival (all-cause and lung cancer-specific).
February 16, 2015
This trial randomized 61 pts to a program of endurance and strength training or no training beginning 5-7 weeks after lung resection for cancer and lasting 20 weeks.  Compared to controls, treatment group patients demonstrated significant improvements in peak O2 uptake, DLCO, leg and arm strength, muscle mass, and QOL.
February 6, 2015
The Centers for Medicare and Medicaid Services (CMS) announced on February 5, 2015, that CT lung cancer screening will be a covered service.  This long awaited decision followed the preliminary announcement in November 2014.  After a period of comment, the coverage ages were expanded to include patients 55-77 years old.  The process mandates maintena

Pages